Advance of molecular imaging technology and targeted imaging agent in imaging and therapy

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Chen, Zhi Yi ^a   Wang, Yi Xiang ^b   Lin, Yan ^a   Zhang, Jin Shan ^a   Yang, Feng ^a   Zhou, Qiu Lan ^a   Liao, Yang Ying ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; APTAMER; CONTRAST MEDIUM; FLUORESCENT DYE; FLUORODEOXYGLUCOSE F 18; INDIUM; LUTETIUM; NANOPARTICLE; PEPTIDE; VASCULOTROPIN RECEPTOR;

AIR TEMPERATURE; ANGIOGENESIS; APOPTOSIS; BIOLUMINESCENCE; CANCER RECURRENCE; CELL MEMBRANE PERMEABILITY; COLLIMATOR; COMPUTER ASSISTED TOMOGRAPHY; CYCLOTRON; DISEASE COURSE; FLUORESCENCE IMAGING; HUMAN; IMAGE RECONSTRUCTION; IMMUNOGENICITY; IONIZING RADIATION; MICROBUBBLE; MOLECULAR IMAGING; MULTIMODAL IMAGING; MULTIMODALITY IMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATION; PHOTON; PLASMA CLEARANCE; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; REVIEW; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THYROID CANCER; TREATMENT RESPONSE; TUMOR GROWTH; ULTRASOUND MOLECULAR IMAGING; WHOLE BODY CT; WHOLE BODY PET; ANIMAL; MOLECULARLY TARGETED THERAPY; PROCEDURES;

ANIMALS; HUMANS; MOLECULAR IMAGING; MOLECULAR TARGETED THERAPY; MULTIMODAL IMAGING;

EID: 84896261496     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/819324     Document Type: Review

References (83)

1. Pan D., Lanza G. M., Wickline S. A., Caruthers S. D., Nanomedicine: perspective and promises with ligand-directed molecular imaging. European Journal of Radiology 2009 70 2 274 285 2-s2.0-67349276371 10.1016/j.ejrad.2009. 01.042
2. Osborn E. A., Jaffer F. A., Advances in molecular imaging of atherosclerotic vascular disease. Current Opinion in Cardiology 2008 23 6 620 628 2-s2.0-55149093175 10.1097/HCO.0b013e328310fc7e
3. Weissleder R., Pittet M. J., Imaging in the era of molecular oncology. Nature 2008 452 7187 580 589 2-s2.0-41649110649 10.1038/nature06917 (Pubitemid 351483372)
4. Atreya R., Goetz M., Molecular imaging in gastroenterology. Nature Reviews Gastroenterology & Hepatology 2013 10 12 704 7712
5. New S. E. P., Aikawa E., Molecular imaging insights into early inflammatory stages of arterial and aortic valve calcification. Circulation Research 2011 108 11 1381 1391 2-s2.0-79957674758 10.1161/CIRCRESAHA.110.234146
6. Gomes C. M., Abrunhosa A. J., Ramos P., Pauwels E. K. J., Molecular imaging with SPECT as a tool for drug development. Advanced Drug Delivery Reviews 2011 63 7 547 554 2-s2.0-79955445971 10.1016/j.addr.2010.09.015
7. Byrne A. T., O'Connor A. E., Hall M., Murtagh J., O'Neill K., Curran K. M., Mongrain K., Rousseau J. A., Lecomte R., McGee S., Callanan J. J., O'Shea D. F., Gallagher W. M., Vascular-targeted photodynamic therapy with BF2-chelated tetraaryl-azadipyrromethene agents: a multi-modality molecular imaging approach to therapeutic assessment. British Journal of Cancer 2009 101 9 1565 1573 2-s2.0-70350654364 10.1038/sj.bjc.6605247
8. Luo S., Zhang E., Su Y., Cheng T., Shi C., A review of NIR dyes in cancer targeting and imaging. Biomaterials 2011 32 29 7127 7138 2-s2.0-79960835810 10.1016/j.biomaterials.2011.06.024
9. James M. L., Gambhir S. S., A molecular imaging primer: modalities, imaging agents, and applications. Physiological Reviews 2012 92 2 897 965 2-s2.0-84860190466 10.1152/physrev.00049.2010
10. Chen K., Chen X., Design and development of molecular imaging probes. Current Topics in Medicinal Chemistry 2010 10 12 1227 1236 2-s2.0-77955645834 10.2174/156802610791384225
11. Anderson C. J., Ferdani R., Copper-64 radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research. Cancer Biotherapy and Radiopharmaceuticals 2009 24 4 379 393 2-s2.0-69249089353 10.1089/cbr.2009.0674
12. Yuan J., Zhang H., Kaur H., Synthesis and characterization of theranostic poly(HPMA)-c(RGDyK)-DOTA-64Cu copolymer targeting tumor angiogenesis: tumor localization visualized by positron emission tomography. Molecular Imaging 2012 12 3 203 212
13. Xavier C., Vaneycken I., D'huyvetter M., Synthesis, preclinical validation, dosimetry, and toxicity of 68Ga-NOTA-Anti-HER2 nanobodies for iPET imaging of HER2 receptor expression in cancer. The Journal of Nuclear Medicine 2013 54 5 776 784
14. Phelps M. E., Positron emission tomography provides molecular imaging of biological processes. Proceedings of the National Academy of Sciences of the United States of America 2000 97 16 9226 9233 2-s2.0-0034241796 10.1073/pnas.97.16.9226 (Pubitemid 30627544)
15. Afshar-Oromieh A., Haberkorn U., Eder M., Eisenhut M., Zechmann C., PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions. European Journal of Nuclear Medicine and Molecular Imaging 2013 40 4 486 495 2-s2.0-84856446906 10.1007/s00259-012-2069-0
16. Beer A. J., Kessler H., Wester H. J., PET imaging of integrin α 3 β v expression. Theranosttiics 2011 1 48 57
17. Pichler B. J., Judenhofer M. S., Pfannenberg C., Multimodal imaging approaches: PET/CT and PET/MRI-part 1. Handbook of Experimental Pharmacology 2008 185 109 132 2-s2.0-52049086903
18. Belkić D., Belkić K., Molecular imaging in the framework of personalized cancer medicine. The Israel Medical Association Journal 2013 15 665 672
19. Andrade W. P., Lima E. N., Osório C. A., do Socorro Maciel M., Baiocchi G., Bitencourt A. G., Fanelli M. F., Damascena A. S., Soares F. A., Can FDG-PET/CT predict early response to neoadjuvant chemotherapy in breast cancer? European Journal of Surgical Oncology 2013 39 12 1358 1363
20. Blake P., Johnson B., VanMeter J. W., Positron emission tomography (PET) and single photon emission computed tomography (SPECT): clinical applications. Journal of Neuro-Ophthalmology 2003 23 1 34 41 2-s2.0-0037336140 10.1097/00041327-200303000-00009 (Pubitemid 36292814)
21. Catafau A. M., Bullich S., Molecular imaging PET and SPECT approaches for improving productivity of antipsychotic drug discovery and development. Current Medicinal Chemistry 2013 20 3 378 388
22. Benadiba M., Luurtsema G., Wichert-Ana L., New molecular targets for PET and SPECT imaging in neurodegenerative diseases. Revista Brasileira de Psiquiatria 2012 34 supplement 2 S125 S148
23. Hijnen N. M., de Vries A., Nicolay K., Grüll H., Dual-isotope111In/177Lu SPECT imaging as a tool in molecular imaging tracer design. Contrast Media and Molecular Imaging 2012 7 2 214 222 2-s2.0-84858721199 10.1002/cmmi.485
24. Hapdey S., Soret M., Buvat I., Quantification in simultaneous 99mTc/123I brain SPECT using generalized spectral factor analysis: a Monte Carlo study. Physics in Medicine and Biology 2006 51 23 6157 6171 2-s2.0-33846871934 10.1088/0031-9155/51/23/015 (Pubitemid 46217656)
25. Blamire A. M., The technology of MRI: the next 10 years? British Journal of Radiology 2008 81 968 601 617 2-s2.0-48249097524 10.1259/bjr/96872829
26. Gore J. C., Manning H. C., Quarles C. C., Waddell K. W., Yankeelov T. E., Magnetic resonance in the era of molecular imaging of cancer. Magnetic Resonance Imaging 2011 29 5 587 600 2-s2.0-79956161755 10.1016/j.mri.2011.02.003
27. Rapley P. L., Witiw C., Rich K., In vitro molecular magnetic resonance imaging detection and measurement of apoptosis using superparamagnetic iron oxide + antibody as ligands for nucleosomes. Physics in Medicine and Biology 2012 57 21 7015 7028
28. Debergh I., Van Damme N., De Naeyer D., Smeets P., Demetter P., Robert P., Carme S., Pattyn P., Ceelen W., Molecular imaging of tumor-associated angiogenesis using a novel magnetic resonance imaging contrast agent targeting α v β 3 integrin. Annals of Surgical Oncology 2013 10.1245/s10434-013-3444-1
29. Sawall S., Kuntz J., Socher M., Imaging of cardiac perfusion of free-breathing small animals using dynamic phase-correlated micro-CT. Medical Physics 2012 39 12 7499 7506
30. Johnston S. M., Johnson G. A., Badea C. T., Temporal and spectral imaging with micro-CT. Medical Physics 2012 39 8 4943 4958
31. Schaap J., de Groot J. A., Nieman K., Hybrid myocardial perfusion SPECT/CT coronary angiography and invasive coronary angiography in patients with stable angina pectoris lead to similar treatment decisions. Heart 2013 99 3 188 194
32. Popovtzer R., Agrawal A., Kotov N. A., Popovtzer A., Balter J., Carey T. E., Kopelman R., Targeted gold nanoparticles enable molecular CT imaging of cancer. Nano Letters 2008 8 12 4593 4596 2-s2.0-61649105001 10.1021/nl8029114
33. Hyafil F., Cornily J.-C., Feig J. E., Gordon R., Vucic E., Amirbekian V., Fisher E. A., Fuster V., Feldman L. J., Fayad Z. A., Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography. Nature Medicine 2007 13 5 636 641 2-s2.0-34249731971 10.1038/nm1571 (Pubitemid 46828482)
34. Pan D., Williams T. A., Senpan A., Allen J. S., Scott M. J., Gaffney P. J., Wickline S. A., Lanza G. M., Detecting vascular biosignatures with a colloidal, radio-opaque polymeric nanoparticle. Journal of the American Chemical Society 2009 131 42 15522 15527 2-s2.0-70350332463 10.1021/ja906797z
35. Li J., Chaudhary A., Chmura S. J., Pelizzari C., Rajh T., Wietholt C., Kurtoglu M., Aydogan B., A novel functional CT contrast agent for molecular imaging of cancer. Physics in Medicine and Biology 2010 55 15 4389 4397 2-s2.0-78049438538 10.1088/0031-9155/55/15/013
36. Rotman M., Snoeks T. J. A., van der Weerd L., Pre-clinical optical imaging and MRI for drug development in Alzheimer's disease. Drug Discovery Today 2011 8 2-4 e117 e125 2-s2.0-82255183294 10.1016/j.ddtec.2011.11.005
37. Edgington L. E., Berger A. B., Blum G., Albrow V. E., Paulick M. G., Lineberry N., Bogyo M., Noninvasive optical imaging of apoptosis by caspase-targeted activity-based probes. Nature Medicine 2009 15 8 967 973 2-s2.0-68349148319 10.1038/nm.1938
38. Niu G., Zhu L., Ho D. N., Longitudinal bioluminescence imaging of the dynamics of Doxorubicin induced apoptosis. Theranostics 2013 3 3 190 200
39. Atreya R., Waldner M. J., Neurath M. F., Molecular imaging: interaction between basic and clinical science. Gastroenterology Clinics of North America 2010 39 4 911 922 2-s2.0-78549284263 10.1016/j.gtc.2010.08.025
40. Bzyl J., Lederle W., Palmowski M., Kiessling F., Molecular and functional ultrasound imaging of breast tumors. European Journal of Radiology 2012 81 supplement 1 S11 S12
41. Deshpande N., Needles A., Willmann J. K., Molecular ultrasound imaging: current status and future directions. Clinical Radiology 2010 65 7 567 581 2-s2.0-77953267632 10.1016/j.crad.2010.02.013
42. Li P., Zheng Y., Ran H., Tan J., Lin Y., Zhang Q., Ren J., Wang Z., Ultrasound triggered drug release from 10-hydroxycamptothecin-loaded phospholipid microbubbles for targeted tumor therapy in mice. Journal of Controlled Release 2012 162 2 349 354
43. Sutton J. T., Haworth K. J., Pyne-Geithman G., Holland C. K., Ultrasound-mediated drug delivery for cardiovascular disease. Expert Opinion on Drug Delivery 2013 10 5 573 592
44. Mancini M., Greco A., Salvatore G., Liuzzi R., di Maro G., Vergara E., Chiappetta G., Pasquinelli R., Brunetti A., Salvatore M., Imaging of thyroid tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. BMC Medical Imaging 2013 13, article 31 10.1186/1471-2342-13-31
45. Li P., Zheng Y., Ran H., Tan J., Lin Y., Zhang Q., Ren J., Wang Z., Ultrasound triggered drug release from 10-hydroxycamptothecin-loaded phospholipid microbubbles for targeted tumor therapy in mice. Journal of Controlled Release 2012 162 2 349 354
46. Chen Z.-Y., Liang K., Qiu R. X., Targeted gene delivery in tumor xenografts by the combination of ultrasound-targeted microbubble destruction and polyethylenimine to inhibit survivin gene expression and induce apoptosis. Journal of Experimental and Clinical Cancer Research 2010 29 1 1 9 2-s2.0-78650516785 10.1186/1756-9966-29-152
47. Cai W., Chen X., Nanoplatforms for targeted molecular imaging in living subjects. Small 2007 3 11 1840 1854 2-s2.0-36048993546 10.1002/smll.200700351 (Pubitemid 350099850)
48. Lin Y., Chen Z. Y., Yang F., Ultrasound-based multimodal molecular imaging and functional ultrasound contrast agents. Current Pharmaceutical Design 2013 19 18 3342 3351
49. Poeppel T. D., Krause B. J., Heusner T. A., Boy C., Bockisch A., Antoch G., PET/CT for the staging and follow-up of patients with malignancies. European Journal of Radiology 2009 70 3 382 392 2-s2.0-67349238288 10.1016/j.ejrad.2009. 03.051
50. Cai W., Niu G., Chen X., Multimodality imaging of the HER-kinase axis in cancer. European Journal of Nuclear Medicine and Molecular Imaging 2008 35 1 186 208 2-s2.0-36849056542 10.1007/s00259-007-0560-9 (Pubitemid 350234146)
51. Cai W., Chen X., Multimodality molecular imaging of tumor angiogenesis. The Journal of Nuclear Medicine 2008 49 supplement 2 113S 128S (Pubitemid 351948040)
52. Browning Z. S., Wilkes A. A., Mackenzie D. S., Using PET/CT imaging to characterize 18 F-fluorodeoxyglucose utilization in fish. Journal of Fish Diseases 2013 36 11 911 919
53. Abgral R., Querellou S., Potard G., Le Roux P.-Y., Le Duc-Pennec A., Marianovski R., Pradier O., Bizais Y., Kraeber-Bodéré F., Salaun P. Y., Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up? Journal of Nuclear Medicine 2009 50 1 24 29 2-s2.0-58249112149 10.2967/jnumed.108.055806
54. Lee W. W., Marinelli B., Van Der Laan A. M., Sena B. F., Gorbatov R., Leuschner F., Dutta P., Iwamoto Y., Ueno T., Begieneman M. P. V., Niessen H. W. M., Piek J. J., Vinegoni C., Pittet M. J., Swirski F. K., Tawakol A., Di Carli M., Weissleder R., Nahrendorf M., PET/MRI of inflammation in myocardial infarction. Journal of the American College of Cardiology 2012 59 2 153 163 2-s2.0-84855363554 10.1016/j.jacc.2011.08.066
55. Kjær A., Loft A., Law I., PET/MRI in cancer patients: first experiences and vision from Copenhagen. Magnetic Resonance Materials in Physics, Biology and Medicine 2012 26 1 37 47
56. Li B., Abran M., Matteau-Pelletier C., Rouleau L., Lam T., Sharma R., Rhéaume E., Kakkar A., Tardif J.-C., Lesage F., Low-cost three-dimensional imaging system combining fluorescence and ultrasound. Journal of Biomedical Optics 2011 16 12 126010 2-s2.0-84860563487
57. Agrawal P., Strijkers G. J., Nicolay K., Chitosan-based systems for molecular imaging. Advanced Drug Delivery Reviews 2010 62 1 42 58 2-s2.0-75349088065 10.1016/j.addr.2009.09.007
58. McDonald M. A., Wang P. C., Siegel E. L., Protein nanospheres: synergistic nanoplatform-based probes for multimodality imaging. Reporters, Markers, Dyes, Nanoparticles, and Molecular Probes for Biomedical Applications III January 2011 San Francisco, Calif, USA Proceedings of SPIE 2-s2.0-79955162174 10.1117/12.876081
59. Kenny G. D., Kamaly N., Kalber T. L., Brody L. P., Sahuri M., Shamsaei E., Miller A. D., Bell J. D., Novel multifunctional nanoparticle mediates siRNA tumour delivery, visualisation and therapeutic tumour reduction in vivo. Journal of Controlled Release 2011 149 2 111 116 2-s2.0-78651352062 10.1016/j.jconrel.2010.09.020
60. Evangelista L., Cervino A. R., Chondrogiannis S., Marzola M. C., Maffione A. M., Colletti P. M., Muzzio P. C., Rubello D., Comparison between anatomical cross-sectional imaging and 18F-FDG PET/CT in the staging, restaging, treatment response, and long-term surveillance of squamous cell head and neck cancer: a systematic literature overview. Nuclear Medicine Communications 2014 35 2 123 134
61. Ren B. X., Yang F., Zhu G. H., Huang Z. X., Ai H., Xia R., Liu X. J., Lu M., Song B., Magnetic resonance tumor targeting imaging using gadolinium labeled human telomerase reverse transcriptase antisense probes. Cancer Science 2012 103 8 1434 1439
62. Gao J., Zheng H., Illuminating the lipidome to advance biomedical research: peptide-based probes of membrane lipids. Future Medicinal Chemistry 2013 5 8 947 959
63. Hansen L., Unmack Larsen E. K., Nielsen E. H., Iversen F., Liu Z., Thomsen K., Pedersen M., Skrydstrup T., Nielsen N. C., Ploug M., Kjems J., Targeting of peptide conjugated magnetic nanoparticles to urokinase plasminogen activator receptor (uPAR) expressing cells. Nanoscale 2013 5 17 8192 8201
64. Hackel B. J., Kimura R. H., Miao Z., 18F-Fluorobenzoate-labeled cystine knot peptides for PET imaging of integrin α v β 6. Nanoscale 2013 55 7 1101 1105
65. Oliveira S., Heukers R., Sornkom J., Kok R. J., van Bergen en Henegouwen P. M., Targeting tumors with nanobodies for cancer imaging and therapy. Journal of Controlled Release 2013 172 3 607 617
66. 61/64Cu-labeled Fab antibody fragment. European Journal of Nuclear Medicine and Molecular Imaging 2013 40 5 759 767
67. Abdolahi M., Shahbazi-Gahrouei D., Laurent S., Sermeus C., Firozian F., Allen B. J., Boutry S., Muller R. N., Synthesis and in vitro evaluation of MR molecular imaging probes using J591 mAb-conjugated SPIONs for specific detection of prostate cancer. Contrast Media & Molecular Imaging 2013 8 2 175 184
68. Bouchard P. R., Hutabarat R. M., Thompson K. M., Discovery and development of therapeutic aptamers. Annual Review of Pharmacology and Toxicology 2010 50 237 257 2-s2.0-77649103704 10.1146/annurev.pharmtox.010909. 105547
69. Keefe A. D., Pai S., Ellington A., Aptamers as therapeutics. Nature Reviews Drug Discovery 2010 9 7 537 550 2-s2.0-77954220072 10.1038/nrd3141
70. Hong H., Goel S., Zhang Y., Cai W., Molecular imaging with nucleic acid aptamers. Current Medicinal Chemistry 2011 18 27 4195 4205 2-s2.0-80052257765 10.2174/092986711797189691
71. Shi H., He X., Wang K., Wu X., Ye X., Guo Q., Tan W., Qing Z., Yang X., Zhou B., Activatable aptamer probe for contrast-enhanced in vivo cancer imaging based on cell membrane protein-triggered conformation alteration. Proceedings of the National Academy of Sciences of the United States of America 2011 108 10 3900 3905 2-s2.0-79952775709 10.1073/pnas.1016197108
72. Bagalkot V., Zhang L., Levy-Nissenbaum E., Jon S., Kantoff P. W., Langery R., Farokhzad O. C., Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on Bi-fluorescence resonance energy transfer. Nano Letters 2007 7 10 3065 3070 2-s2.0-36248973801 10.1021/nl071546n (Pubitemid 350132931)
73. Hwang D. W., Ko H. Y., Lee J. H., Kang H., Ryu S. H., Song I. C., Lee D. S., Kim S., A nucleolin-targeted multimodal nanoparticle imaging probe for tracking cancer cells using an aptamer. Journal of Nuclear Medicine 2010 51 1 98 105 2-s2.0-75149193491 10.2967/jnumed.109.069880
74. Louie A., Multimodality imaging probes: design and challenges. Chemical Reviews 2010 110 5 3146 3195 2-s2.0-77952537647 10.1021/cr9003538
75. Hall M. A., Kwon S., Robinson H., Lachance P.-A., Azhdarinia A., Ranganathan R., Price R. E., Chan W., Sevick-Muraca E. M., Imaging prostate cancer lymph node metastases with a multimodality contrast agent. Prostate 2012 72 2 129 146 2-s2.0-84455203881 10.1002/pros.21413
76. Madani S. Y., Shabani F., Dwek M. V., Conjugation of quantum dots on carbon nanotubes for medical diagnosis and treatment. International Journal of Nanomedicine 2013 8 941 950
77. John R., Nguyen F. T., Kolbeck K. J., Chaney E. J., Marjanovic M., Suslick K. S., Boppart S. A., Targeted multifunctional multimodal protein-shell microspheres as cancer imaging contrast agents. Molecular Imaging and Biology 2012 14 17 24 2-s2.0-79551567714 10.1007/s11307-011-0473-7
78. Ma J., Huang P., He M., Folic acid-conjugated LaF3:Yb,Tm@SiO2 nanoprobes for targeting dual-modality imaging of upconversion luminescence and X-ray computed tomography. The Journal of Physical Chemistry B 2012 116 48 14062 14070
79. Liu Z., Lammers T., Ehling J., Fokong S., Bornemann J., Kiessling F., Gätjens J., Iron oxide nanoparticle-containing microbubble composites as contrast agents for MR and ultrasound dual-modality imaging. Biomaterials 2011 32 26 6155 6163 2-s2.0-79959906653 10.1016/j.biomaterials.2011.05.019
80. Liang M., Liu X., Cheng D., Liu G., Dou S., Wang Y., Rusckowski M., Hnatowich D. J., Multimodality nuclear and fluorescence tumor imaging in mice using a streptavidin nanoparticle. Bioconjugate Chemistry 2010 21 7 1385 1388 2-s2.0-77954871491 10.1021/bc100081h
81. Willmann J. K., Cheng Z., Davis C., Lutz A. M., Schipper M. L., Nielsen C. H., Gambhir S. S., Targeted microbubbles for imaging tumor angiogenesis: assessment of whole-body biodistribution with dynamic micro-pet in mice. Radiology 2008 249 1 212 219 2-s2.0-53749084254 10.1148/radiol.2491072050
82. Deshpande N., Needles A., Willmann J. K., Molecular ultrasound imaging: current status and future directions. Clinical Radiology 2010 65 7 567 581 2-s2.0-77953267632 10.1016/j.crad.2010.02.013
83. Yan F., Li X., Jin Q., Jiang C., Zhang Z., Ling T., Qiu B., Zheng H., Therapeutic ultrasonic microbubbles carrying paclitaxel and LyP-1 peptide: preparation, characterization and application to ultrasound-assisted chemotherapy in breast cancer cells. Ultrasound in Medicine and Biology 2011 37 5 768 779 2-s2.0-79954630255 10.1016/j.ultrasmedbio.2011.02.006